Minneapolis
89°F
eEdition
News & Politics
Sports
Food & Culture
Business
Outdoors
Opinion
Things To Do
Obituaries
More of What Matters to Minnesota
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Minnesota State Top Stocks
Markets
Minnesota Stocks
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Astri Therapeutics Inc
(NQ:
ATXS
)
9.980
-0.510 (-4.86%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 14, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Astri Therapeutics Inc
< Previous
1
2
3
4
5
Next >
Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 02, 2022
From
Astria Therapeutics, Inc.
Via
Business Wire
Astria Therapeutics Reports Second Quarter 2022 Financial Results and Provides a Corporate Update
August 09, 2022
From
Astria Therapeutics, Inc.
Via
Business Wire
Recap Of Thursday's Biotech Catalysts - End Of the Day Summary
August 04, 2022
The European Commission (EC) has approved AstraZeneca (NASDAQ: AZN) and Merck’s (NYSE: MRK) LYNPARZA as monotherapy or in combination with endocrine therapy for the adjuvant treatment of adult patients...
Via
Benzinga
Astria Therapeutics Commences Initial-Stage Skin Disorder Study, Sees Preliminary Data By Year-end
August 04, 2022
Astria Therapeutics (NASDAQ: ATXS) announced initiation of a Phase 1a clinical trial of STAR-0215 in healthy subjects. STAR-0215 is designed to provide long-acting, effective attack prevention for...
Via
Benzinga
Astria Therapeutics Announces Initiation of Phase 1a Trial of STAR-0215, a Monoclonal Antibody Inhibitor of Plasma Kallikrein for Treatment of Hereditary Angioedema
August 04, 2022
From
Astria Therapeutics, Inc.
Via
Business Wire
Astria Therapeutics to Present at Upcoming Wedbush PacGrow Healthcare Conference 2022
August 03, 2022
From
Astria Therapeutics, Inc.
Via
Business Wire
Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 02, 2022
From
Astria Therapeutics, Inc.
Via
Business Wire
Recap Of Thursday's Biotech Catalysts - End of The Day Summary
July 28, 2022
Via
Benzinga
Astria Therapeutics Gets FDA Nod For Initial-Stage Hereditary Angioedema Study
July 28, 2022
The U.S. Food and Drug Administration (FDA) announced clearance to Astria Therapeutics’ (NASDAQ: ATXS) Investigational New Drug (IND) application for STAR-0215 in the treatment of Hereditary Angioedema...
Via
Benzinga
Daily Biotech Pulse: GSK's Kidney Disease Drug Approved For Children, Tonix Pharma To Launch Monkeypox Vaccine Study In Kenya, Positive Effect Of Cyclerion's Schizophrenia Candidate
July 28, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Astria Therapeutics Announces FDA Clearance of IND Application for STAR-0215, a Monoclonal Antibody Inhibitor of Plasma Kallikrein for Treatment of Hereditary Angioedema
July 28, 2022
From
Astria Therapeutics, Inc.
Via
Business Wire
Astria Therapeutics Names Chris Morabito Chief Medical Officer
July 15, 2022
From
Astria Therapeutics, Inc.
Via
Business Wire
Astria Therapeutics to Participate in Virtual Fireside Chat at Upcoming H.C. Wainwright 1st Annual Hereditary Angioedema Conference
July 14, 2022
From
Astria Therapeutics, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Friday's After-Market Session
July 08, 2022
Gainers Passage Bio (NASDAQ:PASG) shares moved upwards by 7.7% to $2.66 during Friday's after-market session. The market value of their outstanding shares is at $144.4 million.
Via
Benzinga
Astria Therapeutics Presents New Preclinical Data Showing Differentiated Profile of STAR-0215, in Development for Treatment of Hereditary Angioedema
July 05, 2022
From
Astria Therapeutics, Inc.
Via
Business Wire
Astria Therapeutics to Present New Preclinical STAR-0215 Data at the European Academy of Allergy and Clinical Immunology 2022 Hybrid Congress
June 23, 2022
From
Astria Therapeutics, Inc.
Via
Business Wire
Astria Therapeutics to Present at Upcoming Jefferies Healthcare Conference
June 03, 2022
From
Astria Therapeutics
Via
Business Wire
Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
June 02, 2022
From
Astria Therapeutics, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Wednesday's Intraday Session
June 01, 2022
Via
Benzinga
62 Biggest Movers From Yesterday
June 02, 2022
Gainers Missfresh Limited (NASDAQ: MF) jumped 51.1% to close at $0.2450 on Wednesday.
Via
Benzinga
Astria Therapeutics Reports First Quarter 2022 Financial Results and Provides a Corporate Update
May 12, 2022
From
Astria Therapeutics, Inc.
Via
Business Wire
Astria Therapeutics to Present STAR-0215 Data at the 2022 Fc Receptor and IgG Targeted Therapies Conference
April 21, 2022
From
Astria Therapeutics, Inc.
Via
Business Wire
Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
April 04, 2022
From
Astria Therapeutics, Inc.
Via
Business Wire
(ATXS) - Analyzing Astria Therapeutics Inc. - Common Stock's Short Interest
March 21, 2022
Astria Therapeutics Inc. - Common Stock's (NASDAQ:ATXS) short percent of float has fallen 18.83% since its last report. The company recently reported that it has 150.40 thousand...
Via
Benzinga
Astria Therapeutics to Present STAR-0215 Data at the 2022 American Academy of Allergy, Asthma and Immunology Annual Meeting
February 18, 2022
From
Astria Therapeutics, Inc.
Via
Business Wire
50 Biggest Movers From Friday
February 07, 2022
Also check out this: Executives Sell Over $45M Of 5 Stocks Losers Ra Medical Systems, Inc. (NYSE: RMED) shares dipped 48.8% to close at $0.3599 on Friday after the...
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
February 04, 2022
Gainers iRadimed (NASDAQ:IRMD) stock rose 15.0% to $45.19 during Friday's regular session. Trading volume for iRadimed's stock is 94.1K as of 12:30 EST. This is...
Via
Benzinga
64 Biggest Movers From Yesterday
February 01, 2022
Gainers Calithera Biosciences, Inc. (NASDAQ: CALA) shares surged 55.7% to settle at $0.65 on Monday after Ladenburg Thalmann initiated coverage on the stock with a...
Via
Benzinga
Astria Therapeutics Reports Third Quarter 2021 Financial Results and Provides a Corporate Update
November 10, 2021
From
Astria Therapeutics, Inc.
Via
Business Wire
The Daily Biotech Pulse: Valneva Inks COVID-19 Vaccine Supply Contract In Europe, I-Mab Spikes On China Deal, DermTech Sinks On Guidance
November 10, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus MorphoSys COO To Leave To Pursue Other Opportunities MorphoSys AG (NASDAQ:...
Via
Benzinga
Exposures
COVID-19
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.